55 . . , . 137.
(. . 3), , -
( . . ...
. 93), , , ,
. , -
!
56 50%
-
( . . ... . 20). , -
(PHLS) 1982 ., ,
( 20 -
!), ( 1975 .) -
.
1979 . (-
), : -
6 . , 2,5 .
, ,
2,5 10 , . :
?!.
, , . , .
. 18 . - . . , , ( 11 18 ) , . BOOSTRIX ( ) ADACEL ( )57. (: ) .
: , , , - , . . , : (, , ), , .
|
|
, 0,01%58.
57 American Academy of Pediatrics. Policy statement DOI: 10.1542/peds.2005-3038. Commit-
tee on Infectious Diseases. Prevention of Pertussis Among Adolescents: Recommendations for
Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine.
58 . . , . 134.
()
DPT 1976 . . 1981 . , . . . , , () . , , , , , ; , . , , 59. 1986-87 . , , , , , , ( 11 2800 )60. - 1996 ., . , , ,
59 Uberall M.A.et al. Severe adverse events in a comparative efficacy trial in Germany in infants
receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine or the
Lederle whole-cell component DIP (DIP) or DT vaccine // The Pertussis Vaccine Study Group,
Dev. Biol. Stand. 1997; 89:83-9.
60 1992 .
. 1996 .
-
. Scheibner V. Vaccination... pp. 33-49.
|
|
. , , 61. , . (VAERS) , 62. , 1930- ., , . : . , ( 7 , 4 , 5-6 , 14 )63.
, , , , 1920- ., , , . . ? , , , , , , , , 64.
1985 . DPT (). , DPT . 1990- ., , . , , -
61 Poland G. A.. Acellular pertussis vaccines: new vaccines for an old disease. Lancet 1996;
347:209-10.
62 Geier D. A, Geier M. R. Clinical Implications of Endotoxin Concentrations in Vaccines. Ann.
Pharmacother. 2002; 36:776-80.
63 . . ... . 129.
64 . Geier D. The true...
. DPT , . , , , (, ), . , . , 2001 . .
, , , ( 19,43$) 9$ , , , , , ( , , )65. , , . , .
|
|
, , . .
65 U. S. Institute of Medicine. Vaccine Development. 1985. 57 , , / . , : , , , . , . . Coulter H. L. A Shot... . 209. , , , , . , .
, -
-
. -
, ,
.
-
; ,
.
,
.
( -
) -
.
-
, -
,
.
() -
, , , -
, .
, . -1. 10 , , , 3-4 , , ( , , , , , ). () . : , (- , ), . , . - , , , . . 3-4 , . , . . . , , , , , , . : , , , .
|
|
, , ( 40
1 , , , . , .
41) . 2-3 . 2-3 . , , : , , , .
2-3 4-5 .
2 . . - , 14 3. .
, , , . , -, , . . : , , . , , , , ( ) 4.
. , . , . -
2 (Medicine International 1984,
p. 20 Viral Diseases in Man. 83rd ed., p. 412), -
-
.
3 . ., . . . 2- ., , ., 2000,
. 104.
4 Hussey G. D. Managing Measles. BMJ 1997, 514:1, p. 316. . .
32 , 5. , , .
(, , ) Morbilli. - 8-10 Morbilli 30 2-3 2 . , Pulsatilla 6 12, Sulphur 6. . . . , , , Pulsatilla Sulphur , , Aconitum Euphrasia 7. , , Aconitum Belladonna. , , : , , , , ; , . , .
|
|
5 Lilienthal S. Homeopathic Therapeutics. 1890, republ. Indian Books & Periodicals Publishers,
pp. 690-693.
6 Agrawal Y. R. Prophylactics in Homoeopathy. 3rd ed., Delhi, 2000, p. 29.
, (, - . )
200 {Agrawal Y. R. Measles & Smallpox. Delhi, 1980, p. 13).
7 , -
,
... ,
(Euphrasia officinalis),
, Pulsatilla ...
.
,
. , ,
30 ,
,
,
- . . (1863-1919). . . ,
4- 1899 .,
. . . , 1899, . 19-20. --
(2003).
- :
(), . -
,
(
. . - -. //
. -
. , 1994, . 40).
Aconitum, , 2-3 . Aconitum , , , , , - 8. , Sulphur , , , , ; . , Pulsatilla , , ( Bryonia, , ; ), a Rhus toxicodendron . Kalium bichromicum Pulsatilla, , . . ( ), , , Phosphorus. Euphrasia. . , , , , , , , .
, . Gelsemium ; ; , ; - ( - , Bryonia). . , , Ipecacuanha. . Apis, .
8 Shepherd D. Homeopathy in epidemic diseases. England, 1967, republ. 1996, p. 44. , . 4249.
, , , . Apis , , . , 3-4 , 9.
, , . , . , . , , . , - (Rapid responses) ( ) : () . , , , , . , . , , . , , , , , , , , 10.
. -- , , , . , , . .
9 , . 44-45.
110 http://bmj.bmjjournals.com/cgi/eletters/330/7483/112-d. . ().
. , , , . , , . , , 11.
, , . -- 1:1000 1:2000, , , 12. , , ( , , , ), . , . : , , , , ECHO. , , , 31 24,1% . ,
11 Marufu . et al. Measles complications: the importance of their management in reducing
mortality attributed to measles. Cent. Afr. J. Med. June 1997; 43:162-5.
12 . . : -
,
, 1:1000
, , -
, ,
1:10 000 1:100 000 {Mendelsohn R. The truth about immunization. The
People's Doctor April 1978). ,
1 5000 , 15%, 20-40%
(UK Department of Health Immunisation
against Infectious Disease 1996. The Green Book. 22.1.4). ,
, , , .
,
.
, , .